{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T22:57:09Z","timestamp":1767913029818,"version":"3.49.0"},"reference-count":21,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2001,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>To characterize changes in serum cytokine levels in human immunodeficiency virus type 1 (HIV-1)-infected persons with<jats:italic>Mycobacterium avium<\/jats:italic>complex (MAC) bacteremia, the levels of IL-1\u03b1 (interleukin-1\u03b1), IL-6, IL-10, tumor necrosis factor alpha (TNF-<jats:italic>\u03b1<\/jats:italic>), soluble type II TNF receptor (sTNF-RII), and transforming growth factor<jats:italic>\u03b2<\/jats:italic>(TGF-<jats:italic>\u03b2<\/jats:italic>) in serum were measured in two cohorts of HIV-1-infected persons with MAC bacteremia. The first cohort was part of a MAC prophylaxis study. Patients with bacteremia were matched with controls without bacteremia. Elevated IL-6, IL-10, TNF-\u03b1, sTNF-RII, and TGF-\u03b2 levels were noted at baseline for all subjects, a result consistent with advanced HIV-1 disease. IL-1\u03b1 was not detected. No differences in cytokine levels in serum were noted at baseline and at the time of bacteremia between patients with MAC and controls. In the second cohort, subjects had serum samples collected at the time of MAC bacteremia and thereafter while on macrolide therapy. Serum samples at time of bacteremia were collected from HIV-1-infected persons at a time when neither highly active antiretroviral therapy (HAART) nor MAC prophylaxis was used routinely. MAC treatment resulted in decreased levels of IL-6 and TNF-\u03b1 in serum, which were evident for IL-6 by 4 to 6 weeks and for TNF-\u03b1 by 8 to 16 weeks. Thus, antibiotic treatment for MAC results in decreased levels of IL-6 and TNF-\u03b1 in serum in HIV-1-infected persons who are not on HAART.<\/jats:p>","DOI":"10.1128\/jcm.39.1.298-303.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:03:40Z","timestamp":1027764220000},"page":"298-303","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":20,"title":["Serum Interleukin-6 (IL-6), IL-10, Tumor Necrosis Factor (TNF) Alpha, Soluble Type II TNF Receptor, and Transforming Growth Factor Beta Levels in Human Immunodeficiency Virus Type 1-Infected Individuals with<i>Mycobacterium avium<\/i>Complex Disease"],"prefix":"10.1128","volume":"39","author":[{"given":"Diane V.","family":"Havlir","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Department of Medicine, University of California, San Diego, California 92103,1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca J.","family":"Torriani","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Medicine, University of California, San Diego, California 92103,1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel D.","family":"Schrier","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Medicine, University of California, San Diego, California 92103,1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimmy Y.","family":"Huang","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Medicine, University of California, San Diego, California 92103,1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"Lederman","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Department of Medicine, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, Ohio 441062"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith A.","family":"Chervenak","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Department of Medicine, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, Ohio 441062"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Henry","family":"Boom","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Department of Medicine, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, Ohio 441062"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.22.1.3400"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/169.2.420"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/315011"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.4049\/jimmunol.161.5.2636","article-title":"Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha","volume":"161","author":"Balcewicz-Sablinska M. K.","year":"1998","unstructured":"Balcewicz-Sablinska M. K. Keane J. Kornfeld H. Remold H. G. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha.J. Immunol.161199826362641","journal-title":"J. Immunol."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4049\/jimmunol.149.2.541","article-title":"Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure","volume":"149","author":"Barnes P. F.","year":"1992","unstructured":"Barnes P. F. Chatterjee D. Abrams J. S. Lu S. Wang E. Yamamura M. Brennan P. J. Modlin R. L. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure.J. Immunol.1491992541547","journal-title":"J. Immunol."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.10.2218.2218"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/515698"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/169.4.739"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1086\/517437"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/173.1.259"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199608083350604"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(98)00091-0"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.4049\/jimmunol.147.4.1201","article-title":"In vitro effect of transforming growth factor-beta on progression of HIV-1 infection in primary mononuclear phagocytes","volume":"147","author":"Lazdins J. K.","year":"1991","unstructured":"Lazdins J. K. Klimkait T. Woods-Cook K. Walker M. Alteri E. Cox D. Cerletti N. Shipman R. Bilbe G. McMaster G. In vitro effect of transforming growth factor-beta on progression of HIV-1 infection in primary mononuclear phagocytes.J. Immunol.147199112011207","journal-title":"J. Immunol."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1086\/315370"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199111000-00006"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1991.7.381"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.4049\/jimmunol.146.9.3165","article-title":"Bidirectional effects of cytokines on the growth of M. avium within human macrophages","volume":"146","author":"Shiratsuchi H.","year":"1991","unstructured":"Shiratsuchi H. Johnson J. Ellner J. J. Bidirectional effects of cytokines on the growth of M. avium within human macrophages.J. Immunol.146199131653170","journal-title":"J. Immunol."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-124-8-199604150-00009"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.1.224-228.1995"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.9.3348"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.1.43"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.39.1.298-303.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.39.1.298-303.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T15:35:20Z","timestamp":1682264120000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.39.1.298-303.2001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["10.1128\/JCM.39.1.298-303.2001"],"URL":"https:\/\/doi.org\/10.1128\/jcm.39.1.298-303.2001","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1]]},"assertion":[{"value":"2000-06-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-10-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}